DTM™ SCS
DTM™ SCS is a proprietary multiplexed programming approach coordinating multiple signals at multiple anatomical targets. In a randomized control trial (RCT) at 12 months, DTM™ SCS provided superior, sustained pain relief compared to conventional stimulation.1
DTM™ SCS endurance
DTM™ SCS endurance is an energy modified, differential target multiplexed programming approach offering more longevity on Vanta™ recharge-free implantable neurostimulator (INS) and longer recharge intervals on rechargeable INS. Results show meaningful pain relief, satisfaction and quality of life improvements at 12 months.2
Inceptiv™ SCS
Inceptiv™ is the most advanced spinal cord stimulation device with closed-loop technology. It senses† and responds, automatically adjusting stimulation moment to moment based on neural responses, maintaining consistent therapy during all patient activities. Inceptiv™ is the smallest and thinnest fully implantable SCS device and offers the best full-body 1.5T and 3T MRI access. ‡
Intellis™ SCS
IntellisTM is a small, high-performance rechargeable neurostimulator. It offers unrivaled battery chemistry with >95% battery capacity at nine years, personalized programming and unimpeded, full-body 1.5T MRI access.‡
Vanta™ SCS
Vanta™ SCS gives you an advantage over pain. This high-performance, recharge-free device offers more longevity, DTM™ SCS endurance waveform, and unimpeded MRI access.‡
Talk to a representative
If you have additional questions about spinal cord stimulation, sign up to speak with a Medtronic representative.
† Sensing signals may not be measurable in all cases.
‡ Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.
1
Fishman M, Cordner H, Justiz R, et al. 12-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021. doi: 10.1111/papr.13066.
2
Peacock, Provenzano, Fishman, et al. Long-Term Clinical Outcomes of a Low-Energy Derivative Study of Differential Target Multiplexed™️ Spinal Cord Stimulation. Poster presented at: North American Neuromodulation Society (NANS) 26th Annual Meeting; Jan 12-15, 2023; Las Vegas, NV.